183 related articles for article (PubMed ID: 7640068)
1. Taxoids.
Kaye SB
Eur J Cancer; 1995; 31A(5):824-6. PubMed ID: 7640068
[No Abstract] [Full Text] [Related]
2. The taxoids: paclitaxel and docetaxel.
Gelmon K
Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
[No Abstract] [Full Text] [Related]
3. Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.
Hortobagyi GN; Kris MG
Semin Oncol; 2002 Jun; 29(3 Suppl 12):1-3. PubMed ID: 12170444
[No Abstract] [Full Text] [Related]
4. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
[TBL] [Abstract][Full Text] [Related]
5. Taxoids: new weapons against cancer.
Nicolaou KC; Guy RK; Potier P
Sci Am; 1996 Jun; 274(6):94-8. PubMed ID: 8643952
[No Abstract] [Full Text] [Related]
6. Paclitaxel and docetaxel in breast and ovarian cancer.
Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
[TBL] [Abstract][Full Text] [Related]
7. Taxing the taxanes: overused or undersold?
Miller M
J Natl Cancer Inst; 1999 Dec; 91(24):2077-8. PubMed ID: 10601377
[No Abstract] [Full Text] [Related]
8. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
9. [Taxanes in the treatment of breast and ovarian cancers: current indications and results].
Espié M; Cuvier C; Gorins A; Marty M
Contracept Fertil Sex; 1998 Nov; 26(11):805-11. PubMed ID: 9864888
[TBL] [Abstract][Full Text] [Related]
10. Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.
Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Howell A
Eur J Cancer; 1997 Nov; 33(13):2183-93. PubMed ID: 9470804
[No Abstract] [Full Text] [Related]
11. Taxoid compounds in breast cancer: current status and future prospects.
Piccart MJ
Cancer Treat Res; 1995; 78():185-207. PubMed ID: 8595143
[No Abstract] [Full Text] [Related]
12. Docetaxel (Taxotere) for advanced breast cancer.
Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
[No Abstract] [Full Text] [Related]
13. A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer.
Lister-Sharp D; McDonagh MS; Khan KS; Kleijnen J
Health Technol Assess; 2000; 4(17):1-113. PubMed ID: 11074389
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel. A review of its role in breast cancer treatment.
Antoine EC; Rixe O; Auclerc G; Weil M; Khayat D
Am J Clin Oncol; 1997 Aug; 20(4):429-32. PubMed ID: 9256905
[No Abstract] [Full Text] [Related]
15. The taxanes: an update.
Crown J; O'Leary M
Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395
[TBL] [Abstract][Full Text] [Related]
16. The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer.
Gogas H; Fountzilas G
Ann Oncol; 2003 May; 14(5):667-74. PubMed ID: 12702519
[No Abstract] [Full Text] [Related]
17. The clinical rationale for developing docetaxel (Taxotere).
Armand JP
Anticancer Drugs; 1996 Aug; 7 Suppl 2():37-9. PubMed ID: 8862710
[TBL] [Abstract][Full Text] [Related]
18. Taxol and taxotere--current status and future prospects.
Bissett D; Kaye SB
Eur J Cancer; 1993; 29A(9):1228-31. PubMed ID: 8102062
[No Abstract] [Full Text] [Related]
19. [Provision of taxoids in 1996: inequality of care].
Eland IA; Otter R; Krommendijk R; Stricker BH
Ned Tijdschr Geneeskd; 1998 Mar; 142(10):518-21. PubMed ID: 9623098
[TBL] [Abstract][Full Text] [Related]
20. The taxoids. Comparative clinical pharmacology and therapeutic potential.
Eisenhauer EA; Vermorken JB
Drugs; 1998 Jan; 55(1):5-30. PubMed ID: 9463787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
